دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Long-Term Changes in Cardiac Structure and Function Following Bariatric Surgery
Hidemi Sorimachi, MD, PHD, a Masaru Obokata, MD, PHD, a Kazunori Omote, MD, P HD, a Yogesh N.V. Reddy, MBBS, MSC ,a Naoki Takahashi, MD, b Katlyn E. Koepp, PH D, a Arnold C.T. Ng, MD, c Oliver J. Rider, MD,d Barry A. Borlaug, MD a
doi : 10.1016/j.jacc.2022.08.738
Volume 80, Issue 16, 18 October 2022, Pages 1501-1512
Studies with short-term follow-up have demonstrated favorable effects of weight loss (WL) on the heart, but little information is available regarding long-term effects or effects of visceral fat reduction.
Weight Loss and Cardiac Reverse Remodeling∗
Paul Heidenreich, MD, MS
doi : 10.1016/j.jacc.2022.08.752
Volume 80, Issue 16, 18 October 2022, Pages 1513-1515
Intensive Blood Pressure Lowering in Patients With Malignant Left Ventricular Hypertrophy
Simon B. Ascher, MD, MPH,a,b James A. de Lemos, MD,c MinJae Lee, P HD, d Elaine Wu, MPH,c Elsayed Z. Soliman, MD, MS C, MS, e Ian J. Neeland, MD,f Dalane W. Kitzman, MD, g Christie M. Ballantyne, MD,h Vijay Nambi, MD, P HD, h,i Anthony A. Killeen, MB, BC H, MS C, P HD, j Joachim H. Ix, MD, MAS, k,l Michael G. Shlipak, MD, MPH,a Jarett D. Berry, MD, MS
doi : 10.1016/j.jacc.2022.08.735
Volume 80, Issue 16, 18 October 2022, Pages 1516-1525
Left ventricular hypertrophy (LVH) combined with elevations in cardiac biomarkers reflecting myocardial injury and neurohormonal stress (malignant LVH) is associated with a high risk for heart failure and death.
Malignant Left Ventricular Hypertrophy and Epidemiology 101∗
Christopher R. deFilippi, MD,a Stephen Seliger, MD, MS
doi : 10.1016/j.jacc.2022.08.736
Volume 80, Issue 16, 18 October 2022, Pages 1526-1528
Dose-Response to Sacubitril/Valsartan in Patients With Heart Failure and Reduced Ejection Fraction
Reza Mohebi, MD, a,b Yuxi Liu, MS, a,b Ileana L. Piña, MD, MPH,c,d,e Margaret F. Prescott, PH D, f Javed Butler, MD, MPH, MBA, g,h G. Michael Felker, MD, i Jonathan H. Ward, PHARMD, f Scott D. Solomon, MD,b,j James L. Januzzi, J R , MD
doi : 10.1016/j.jacc.2022.08.737
Volume 80, Issue 16, 18 October 2022, Pages 1529-1541
Doses of sacubitril/valsartan (Sac/Val) achieved in clinical trials of heart failure with reduced ejection fraction (HFrEF) are often not reached in clinical practice.
Guideline-Directed Medical Therapy: Even a Little Is Better Than None∗
Mary Norine Walsh, MD
doi : 10.1016/j.jacc.2022.08.739
Volume 80, Issue 16, 18 October 2022, Pages 1542-1544
Impact of Clonal Hematopoiesis in Patients With Cardiogenic Shock Complicating Acute Myocardial Infarction
Matthias Böhme, MD, a, * Steffen Desch, MD, b, * Maciej Rosolowski, P HD, c Markus Scholz, PH D, c Knut Krohn, P HD, a Petra Büttner, PHD, b Michael Cross, P HD, a Janine Kirchberg, PH D, a Karl-Philipp Rommel, MD, b Janine Pöss, MD,b Anne Freund, MD,b Ronny Baber, MD, d Berend Isermann, MD,d Uta Ceglarek, PHD, d Klaus H. Metzeler, MD,a Uwe Platzbecker, MD, a,y Holger Thiele, MD
doi : 10.1016/j.jacc.2022.08.740
Volume 80, Issue 16, 18 October 2022, Pages 1545-1556
Clonal hematopoiesis of indeterminate potential (CHIP) is common in elderly individuals and is associated with an increased risk of both hematologic malignancies and cardiovascular disease. The impact of CHIP on the outcomes for patients with cardiogenic shock (CS) complicating acute myocardial infarction (AMI) remains undetermined.
Clonal Hematopoiesis in Cardiogenic Shock: Beyond Conventional Prognostication?∗
D, P HD, a Ghilas Rahoual, MD, a Jean-Sébastien Hulot, MD, P HD
doi : 10.1016/j.jacc.2022.09.002
Volume 80, Issue 16, 18 October 2022, Pages 1557-1559
Advances in Multimodality Imaging in Cardio-Oncology: JACC State-of-the-Art Review
Lauren A. Baldassarre, MD,a Sarju Ganatra, MD,b Juan Lopez-Mattei, MD, c Eric H. Yang, MD, d Vlad G. Zaha, MD, PH D, e,f Timothy C. Wong, MD,g Chadi Ayoub, MD, PH D, h Jeanne M. DeCara, MD, i Susan Dent, MD,j Anita Deswal, MD, MPH,k Arjun K. Ghosh, MBBS, P HD, l,m Mariana Henry, MPH,n Abhishek Khemka, MD, MBA, o Monika Leja, MD, p Lawrence Rudski, MD, q Hector R. Villarraga, MD,r Jennifer E. Liu, MD, s Ana Barac, MD, PHD, t,u Marielle Scherrer-Crosbie, MD, PHD, v on behalf of the ACC Cardio-Oncology and the ACC Imaging Councils
doi : 10.1016/j.jacc.2022.08.743
Volume 80, Issue 16, 18 October 2022, Pages 1560-1578
The population of patients with cancer is rapidly expanding, and the diagnosis and monitoring of cardiovascular complications greatly rely on imaging. Numerous advances in the field of cardio-oncology and imaging have occurred in recent years.
Annual Mortality Related to Pulmonary Embolism in the U.S. Before and During the COVID-19 Pandemic
Ioannis T. Farmakis, MD, MSc Luca Valerio, MD Behnood Bikdeli, MD, MS Jean M. Connors, MD George Giannakoulas, MD, PhD Samuel Z. Goldhaber, MD Lukas Hobohm, MD, PhD Beverley J. Hunt, MD, OBE Karsten Keller, MD, PhD Alex C. Spyropoulos, MD *Stefano Barco, MD, PhD
doi : 10.1016/j.jacc.2022.08.721
Volume 80, Issue 16, 18 October 2022, Pages 1579-1581
High-Dose Statins Increase Adverse Events and Do Not Improve Survival
Simon B. Dimmitt, MBBS, BMedSc(Hons) Hans G. Stampfer, MBBS John B. Warren, MD Jennifer H. Martin, MA, MBChB, PhD
doi : 10.1016/j.jacc.2022.06.045
Volume 80, Issue 16, 18 October 2022, Page e125
Reply: High-Dose Statins Increase Adverse Events and Do Not Improve Survival
Adam J. Nelson, MBBS, MBA, MPH, PhD Neha J. Pagidipati, MD, MPH *Christopher B. Granger, MD
doi : 10.1016/j.jacc.2022.08.741
Volume 80, Issue 16, 18 October 2022, Page e127
Does the Solution Only Lie in the Size of the Aorta?
Antoine Koltz, MD Antoine Canivet, MD *Andrei Codreanu, MD
doi : 10.1016/j.jacc.2022.06.046
Volume 80, Issue 16, 18 October 2022, Page e129
Reply: Does the Solution Only Lie in the Size of the Aorta?
Asvin M. Ganapathi, MD *G. Chad Hughes, MD
doi : 10.1016/j.jacc.2022.08.742
Volume 80, Issue 16, 18 October 2022, Page e131
Statement of Ownership
doi : 10.1016/S0735-1097(22)06899-1
Volume 80, Issue 16, 18 October 2022, Page A28
